MyFinsight
Home
Blog
About
Investment in associates at
fair value
$199,309K
(349.93%↑ Y/Y)
Investments at fair value
$87,367K
(894.05%↑ Y/Y)
Marketable securities
$21,866K
(1147.35%↑ Y/Y)
Other non-marketable
equity securities
$4,124K
(17.03%↑ Y/Y)
Investment in real estate
$1,922K
Operating lease
right-of-use assets
$617K
(-30.05%↓ Y/Y)
Property and equipment,
net
$532K
(-17.52%↓ Y/Y)
Loan to an equity
method investee
$448K
(-82.29%↓ Y/Y)
Amounts funded in
respect of employee...
$49K
(28.95%↑ Y/Y)
Deposits
$2K
(0.00%↑ Y/Y)
Investments at fair value
$34,521K
(-39.99%↓ Y/Y)
Cash and cash
equivalents
$15,245K
(-3.49%↓ Y/Y)
Prepaid expenses and
other current assets
$2,173K
(100.09%↑ Y/Y)
Marketable securities
$846K
(-51.74%↓ Y/Y)
Related parties
receivable
$622K
Total long-term
assets
$316,236K
(404.70%↑ Y/Y)
Total current assets
$53,407K
(-46.07%↓ Y/Y)
Total assets
$369,643K
(128.62%↑ Y/Y)
Total liabilities and
equity
$369,643K
(128.62%↑ Y/Y)
Total stockholders
equity
$317,473K
(106.71%↑ Y/Y)
Total long-term
liabilities
$41,439K
(840.09%↑ Y/Y)
Total current
liabilities
$10,731K
(190.58%↑ Y/Y)
Accumulated deficit
-$6,965K
(95.93%↑ Y/Y)
Additional paid-in capital
$323,943K
(-0.33%↓ Y/Y)
Deferred tax liabilities
$39,544K
Deferred income
$1,209K
(-2.18%↓ Y/Y)
Operating lease
liabilities
$484K
(-25.31%↓ Y/Y)
Dividend payable
$159K
Employee rights upon
retirement
$43K
(19.44%↑ Y/Y)
Accounts payable and
accrued expenses
$8,508K
(294.07%↑ Y/Y)
Deferred income
$1,710K
(38.35%↑ Y/Y)
Dividend payable
$264K
Operating lease
liabilities
$249K
(-5.68%↓ Y/Y)
Common stock, 0.012 par
value (60,000,000...
$495K
(0.81%↑ Y/Y)
Back
Back
Balance Sheet
ORAMED PHARMACEUTICALS INC. (ORMP)
ORAMED PHARMACEUTICALS INC. (ORMP)
source: myfinsight.com